CVS Health Corporation Common Stock (CVS)
Consumer Cyclical › Retail-Drug Stores and Proprietary Stores
Price History
Feb 9, 2026 — May 20, 2026Investment Snapshot
- Trading 116% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 2.3% — below-average profitability
- Revenue growing at 8% annually
CVS Health Corporation Common Stock (CVS) is a Consumer Cyclical company operating in Retail-Drug Stores and Proprietary Stores, listed on the NYSE , with a market capitalisation of $120.2 billion . Key value metrics: P/E ratio 68.0, P/B ratio 1.55, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
CVS Health Corporation Common Stock — Fundamental Analysis Summary
CVS Health Corporation Common Stock (CVS) is currently trading 116% above its Graham Number of $43.50, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 68.0x.
On financial health, CVS shows a moderate Piotroski F-Score of 6/9, and modest return on equity of 2.3% (sector average: 1.5%), and manageable leverage with a debt-to-equity ratio of 0.83.
StockPik's composite Value Score for CVS is 58/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
CVS reports a solid gross margin of 45.2% (sector average: -34.0%) and a modest operating margin of 1.8%.
CVS shows revenue growing at 8% year-over-year, with earnings declining at 62%.
CVS pays a modest dividend yield of 2.8%.